** Deutsche Bank initiates coverage of Tecan Group TECN.S
with "buy" as it sees positive growth prospects for the Swiss
laboratory instruments maker
** "We view the company as well equipped to deliver on its
target for sustained, profitable growth going forward," says DB
** The brokerage says Tecan is "well positioned" thanks to
its leading position in structurally growing markets and its
initiatives to outgrow underlying end-markets
** It adds acquisitions could pose additional upside
potential, given the company's strong balance sheet and
historically beneficial M&A strategy
** "Attractive sales growth should be accompanied by volume
leverage, and thus, increased profitability, further supported
by a shift toward a higher share of recurring sales," it adds
** The brokerage forecasts 6% CAGR for sales, 9% for
adjusted EBITDA and 10% for adjusted EPS between 2022 and 2027
** DB sees good value for investors, with Tecan shares
"trading at 28x 2024E P/E in return for low-teens bottom-line
growth"
** Out of six analysts that cover Tecan, five rate the stock
"strong buy" or "buy" and one "hold" - Refinitiv
(Reporting by Anna Mackenzie)
((Anna.mackenzie@thomsonreuters.com))